 Connection
Marco Del Chiaro to Disease Progression
This is a "connection" page, showing publications Marco Del Chiaro has written about Disease Progression.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.498 |
|
|
|
-
Del Chiaro M, Ateeb Z, Hansson MR, Rangelova E, Segersv?rd R, Kartalis N, Ansorge C, L?hr MJ, Arnelo U, Verbeke C. Survival Analysis and Risk for Progression of Intraductal Papillary Mucinous Neoplasia of the Pancreas (IPMN) Under Surveillance: A Single-Institution Experience. Ann Surg Oncol. 2017 Apr; 24(4):1120-1126.
Score: 0.337
-
L?hr JM, Del Chiaro M. Assessing Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms. JAMA Netw Open. 2020 11 02; 3(11):e2024486.
Score: 0.111
-
Piper M, Van Court B, Mueller A, Watanabe S, Bickett T, Bhatia S, Darragh LB, Mayeda M, Nguyen D, Gadwa J, Knitz M, Corbo S, Morgan R, Lee JJ, Dent A, Goodman K, Messersmith W, Schulick R, Del Chiaro M, Zhu Y, Kedl RM, Lenz L, Karam SD. Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma. Clin Cancer Res. 2022 Mar 01; 28(5):1013-1026.
Score: 0.030
-
Sanjeevi S, Ivanics T, Lundell L, Kartalis N, Andr?n-Sandberg ?, Blomberg J, Del Chiaro M, Ansorge C. Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer. Br J Surg. 2016 Feb; 103(3):267-75.
Score: 0.020
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|